Painreform is trading 5.54% down at $0.92 after declining from its September 2, 2026 close of $0.97; no clear immediate catalyst was identified.

  • No company-specific announcement, earnings release, or regulatory catalyst was identified for September 3, 2026.
  • Available coverage indicates no recent press releases; the latest identified SEC filings were dated July 27 and July 21, 2026.
  • The decline contrasts with a moderately positive broader-market backdrop.